San Diego Bio-Pharma Conference 2010  

June 5, 2010, Hilton San Diego/Del Ma, Del Mar California 

Into its ninth year, this annual symposium strives to strengthen connections between academia and industry, and between technology innovation and product development. The scientific session will feature an array of distinguished speakers presenting most recent advances in the life cycle of drug discovery and development. The interactive panel discussions present strategies to reinvent biopharma R&D business model with the aim to enhance efficiency and success rate from both regional and global perspectives. Through a format of knowledge sharing and networking, the goal is to promote innovation, collaboration, and support advancement of San Diego’s biopharmaceutical research and development.

Normal 0 false false false EN-US ZH-CN X-NONE MicrosoftInternetExplorer4 /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-qformat:yes; mso-style-parent:""; mso-padding-alt:0in 5.4pt 0in 5.4pt; mso-para-margin:0in; mso-para-margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:11.0pt; font-family:"Calibri","sans-serif"; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:SimSun; mso-fareast-theme-font:minor-fareast; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi;}

Confirmed Speakers:

Nancy Chan, Senior Managing Director, Asia and Chairperson of the Asia team, OrbiMed

John Dunn, Executive Vice President, New Ventures, Biogen-Idec

Greg Heath, Senior. VP & General Manager, Diagnostics Business Unit, Illuminar

Steve Kaldor, Ph.D., President and CEO, Ambrx

Ge Li, CEO, Wuxi Apptech

Diego Miralles, Head and Chief Medical Officer, J&J PRD West Coast

Bob More, General Partner, Frazier Healthcare Ventures

Richard Neale, Chief Business Officer, Scripps Clinic

John Oyler (Moderator), BioDuro

Lewis Shuster (Moderator), CEO, Shuster Capital

James Tong, CFO, Chief Business & Development Officer, Tianyin Pharmaceutical, China

Xiaodong Wang, Director, National Institute of Biological Sciences, Beijing China

Troy Wilson,  President and CEO, Intellikine

Steve Yang, Vice President, Head of R&D, Asia at Pfizer

Guo-Liang Yu, President, CEO and Chairman of the Board, Epitomics